UK Regulation: In A System Of Regulatory Reliance, PMS Assumes A Central Role
Why GB’s Post Market Surveillance Requirements Will Differ From EU’s
Taylor Wessing partner Alison Dennis explains why post market surveillance is an MHRA priority as Great Britain’s medical device regulatory system takes shape.
